About

Tackling AMR requires not only understanding it as a biological phenomenon but also understanding how it affects our economies over time. It is by being able to gauge the magnitude of AMR’s economic impact that political/global leaders can compare this problem to other pressing concerns and take action. The Quadripartite is ideally placed to explore this issue given its expertise across all of the relevant sectors. As such, the economics of AMR is a key priority within the Quadripartite mandate. 

The Technical Group (QTG-EA) advises the Quadripartite Organizations and the Global Leaders Group on AMR on the costs imposed by AMR and the benefits reaped in tackling it across the One Health settings – human health, animal health, environmental health, agri-food, and plant health.

The QTG-EA is made up of 20 experts from across the globe.

Core Areas of Work

The work of the Quadripartite on the Economics of AMR is made up of four main components:

• Estimating the economic cost of AMR
• Defining a package of priority interventions and policies across One Health sectors
• Calculating the return on investment from tackling AMR through targeted interventions and policies
• Creating a toolbox for countries to compare and choose amongst interventions and policies to tackle AMR, and to assess the economic rationale underpinning their implementation